Nestlé invests in US brain food maker
date:Jul 21, 2012
rising from $1.198bn to $2.095bn.

This compares with a CAGR of 4.4% for bone and joint health products; 7.7% for digestive and immunity health products and 4.8% for heart health products.

04/19 20:58